Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
52.37 USD | +0.17% | -3.02% | +31.72% |
08/05 | Earnings Flash (KROS) KEROS THERAPEUTICS Reports Q1 Revenue $83,000 | MT |
08/05 | Keros Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+31.72% | 1.89B | |
+9.58% | 115B | |
+12.41% | 107B | |
-12.38% | 22.31B | |
-3.46% | 21.6B | |
-3.35% | 18.23B | |
-38.57% | 17.62B | |
+7.51% | 14.26B | |
+35.67% | 12.37B | |
-24.50% | 8.28B |
- Stock Market
- Equities
- KROS Stock
- News Keros Therapeutics, Inc.
- BTIG Adjusts Price Target on Keros Therapeutics to $105 From $95, Maintains Buy Rating